BHC — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Bausch Health Companies Inc.
Healthcare · $5.35
1.0
/10
Avoid
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-17.1%
Below trend
Volatility
Low
Thin premiums
Momentum
Positive
Price direction
About Bausch Health Companies Inc.
Bausch Health is a diversified specialty pharma company burdened by massive legacy debt and ongoing spinoff uncertainty. No dividend, low beta (~0.4), trades as a restructuring play. CSP premiums are modest — the real risk is litigation and debt-driven tail events, not earnings volatility.
Drug Manufacturers - Specialty & Generic
Market Cap
$2.0B
P/E Ratio
12.7
Beta
0.40
52-Week Range Current: $5.35
$4.25 $8.69
Earnings
2026-04-29
24 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE